Anmeldung erfolgt in Kürze...
Details werden geladen...
NPPA slashes cancer drug MRPs by up to 93%; Thiotepa cut by ₹72,921 | Mint
The drug pricing regulator has slashed retail prices of 543 formulations across 137 non-scheduled cancer medicines, with some cuts exceeding 90% under a trade margin rationalisation framework.
Ähnliche Seiten
Cancer drug prices slashed by up to 90%; new rates effective from November 9 - The Tribune
https://www.tribuneindia.com/news/india/cancer-drug-prices-slashed-by-up-to-90-new-rates-effective-from-november-9/
Centre plans 30% trade-margin cap on non-scheduled cancer drugs | Mint
https://www.livemint.com/industry/centre-plans-30-trade-margin-cap-on-non-scheduled-cancer-drugs-11791462383407.htmlCancer drug prices may fall up to 70% from November 9 — What to know | Today News
https://www.livemint.com/news/india/cancer-drug-prices-may-fall-up-to-70-from-november-9-what-to-know-11792271202157.htmlCentre caps trade margins on 137 cancer drugs, prices likely to fall by up to 70% | Mint
https://www.livemint.com/industry/centre-caps-trade-margins-on-137-cancer-drugs-prices-likely-fall-by-up-to-70-11792248570646.html
India's NPPA Slashes Cancer Drug Prices by Up to 93%, But Gaps Remain - Rediff.com Business
https://www.rediff.com/business/report/indias-nppa-slashes-cancer-drug-prices-by-up-to-93-but-gaps-remain/20261029.htm